Co-Diagnostics, Inc. Deferred Tax Liabilities, Other
Co-Diagnostics, Inc. (CODX) had Deferred Tax Liabilities, Other of $6.76 thousand as of 2021-12-31, per its 10-K filed 2023-03-16.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesOther · last filed 2023-03-16
- 2021-12-31: Deferred Tax Liabilities, Other $6.76K.
- 2020-12-31: Deferred Tax Liabilities, Other $54.97K.
| Period end | Deferred Tax Liabilities, Other |
|---|---|
| 2021-12-31 | $6.76K 10-K · filed 2023-03-16 |
| 2020-12-31 | $54.97K 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |